Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

BACKGROUND: Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from a UK National Health Service (NHS) perspective. METHODS: A linked-equation mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Dhvani, Driessen, Maurice, Risebrough, Nancy, Baker, Timothy, Naya, Ian, Briggs, Andrew, Ismaila, Afisi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946544/
https://www.ncbi.nlm.nih.gov/pubmed/29773969
http://dx.doi.org/10.1186/s12962-018-0101-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946544/
https://www.ncbi.nlm.nih.gov/pubmed/29773969
http://dx.doi.org/10.1186/s12962-018-0101-3

Ejemplares similares